We have found that tapering off semaglutide by gradually decreasing the dosage can be efficacious in reducing large spikes in appetite following cycle cessation, increasing the likelihood of long-term results
It is biology, a connected system that links cortisol, the gut microbiome, SCFAs, neurotransmitters, inflammation, and GLP-1, the hormone that helps signal fullness
May your research stay rigorous, your peptides stay pure, and your protocols stay productive.
E.BurtonD.ShinA.JeongI
A few, like KPV, have an anti-inflammatory rationale extrapolated from preclinical research, but that is experimental, not proven
What supports this recommendation (from the Phase 3 C-POST trial): Median disease-free survival was not reached in the cemiplimab arm vs 49.4 months in the placebo arm (HR 0.32